RetinalGenix Technologies (RTGN) Accumulated Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) posted Accumulated Expenses of $20239.0 for Q1 2026, up 4.98% sequentially from $19279.0 in Q4 2025, and up 23.42% YoY from $16399.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Accumulated Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Accumulated Expenses for 6 years, with the latest figure at $20239.0 in Q1 2026.
- Quarterly Accumulated Expenses rose 23.42% year-over-year to $20239.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20239.0 (up 23.42% YoY) and the FY2025 annual result came in at $19279.0, up 24.87% from the prior year.
- Accumulated Expenses advanced to $20239.0 in Q1 2026 per RTGN's latest filing, from $19279.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $20239.0 in Q1 2026 and troughed at $4079.0 in Q1 2022.
- A 5-year average of $12494.3 and a median of $12559.0 in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2026: Accumulated Expenses surged 476.19% in 2022, then advanced 23.42% in 2026.
- Over 5 years, Accumulated Expenses stood at $7759.0 in 2022, then jumped by 49.49% to $11599.0 in 2023, then surged by 33.11% to $15439.0 in 2024, then increased by 24.87% to $19279.0 in 2025, then increased by 4.98% to $20239.0 in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $20239.0, $19279.0, and $18319.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,239.00 |
| Dec 31, 2025 | 19,279.00 |
| Sep 30, 2025 | 18,319.00 |
| Jun 30, 2025 | 17,359.00 |
| Mar 31, 2025 | 16,399.00 |
| Dec 31, 2024 | 15,439.00 |
| Sep 30, 2024 | 14,479.00 |
| Jun 30, 2024 | 13,519.00 |
| Mar 31, 2024 | 12,559.00 |
| Dec 31, 2023 | 11,599.00 |
| Sep 30, 2023 | 10,639.00 |
| Jun 30, 2023 | 9,679.00 |
| Mar 31, 2023 | 8,719.00 |
| Dec 31, 2022 | 7,759.00 |
| Sep 30, 2022 | 6,799.00 |
| Jun 30, 2022 | 5,539.00 |
| Mar 31, 2022 | 4,079.00 |
| Dec 31, 2021 | 2,619.00 |
| Sep 30, 2021 | 1,180.00 |